SCHEMBL6187055

SCHEMBL6187055

O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3Sc3ccccc32)CC1)c1ccccc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTTP P55157 8/20 0.64
ADRA1A P35348 2/20 0.64
CHRM2 P08172 1/20 0.64
ADRA2A P08913 1/20 0.64
ADORA3 P0DMS8 1/20 0.64
CHRM1 P11229 1/20 0.64
DRD1 P21728 1/20 0.64
TBXA2R P21731 1/20 0.64
PTGS1 P23219 1/20 0.64
SLC6A2 P23975 1/20 0.64
OPRM1 P35372 1/20 0.64
DRD3 P35462 1/20 0.64
SLC6A3 Q01959 1/20 0.64
KCNH2 Q12809 1/20 0.64
MTR Q99707 1/20 0.64
ADRA1D P25100 1/20 0.49
ADRA1B P35368 1/20 0.49
CARM1 Q86X55 1/20 0.46
PRMT6 Q96LA8 1/20 0.46
DRD4 P21917 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6187290 0.91 MTTP (0.77) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL6187452 0.87 MTTP (0.61) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL6187285 0.86 MTTP (0.56) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL6187020 0.85 MTTP (0.65) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL8895116 0.82 MTTP (0.56) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL8891504 0.81 MTTP (0.67) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL8895013 0.81 MTTP (0.51) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL8891745 0.81 MTTP (0.66) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL8895668 0.80 MTTP (0.59) MTTPADRA1ACHRM2ADRA2AADORA3
SCHEMBL6602458 0.79 MTTP (0.72) MTTPADRA1ACHRM2ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0886637-B9 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL MYERS SQUIBB CO (US) 2005-05-04 EP claimed
EP-0886637-B1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL MYERS SQUIBB CO (US) 2004-12-01 EP claimed
WO-1996026205-A1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 1996-08-29 WO claimed
EP-0886637-B9 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL MYERS SQUIBB CO (US) 2005-05-04 EP disclosed
EP-0886637-B1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL MYERS SQUIBB CO (US) 2004-12-01 EP disclosed
US-6066650-A USEFUL FOR LOWERING SERUM LIPIDS AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-05-23 US disclosed
US-6034098-A ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-03-07 US disclosed
EP-0886637-A4 1998-12-30 EP disclosed
EP-0886637-A1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 1998-12-30 EP disclosed
WO-1996026205-A1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 1996-08-29 WO disclosed